Senator Cassidy Critiques Kennedy's Vaccine Panel Overhaul Amid CDC Resignations
Senator Bill Cassidy criticized Robert F. Kennedy Jr.'s overhaul of a vaccine panel, coinciding with multiple CDC officials resigning over vaccine policy disagreements.
Overview
- Senator Bill Cassidy expressed concerns about Robert F. Kennedy Jr.'s changes to a vaccine advisory panel.
- Multiple CDC officials resigned due to conflicts with the Trump administration's vaccine policies.
- The resignations were linked to disagreements over COVID-19 vaccine recommendations for children.
- Kennedy appointed 17 new members to the Advisory Committee for Immunization Practices, many of whom are vaccine skeptics.
- Calls have emerged to postpone upcoming vaccine advisory meetings due to the panel's overhaul.
Report issue
Read both sides in 5 minutes each day
Analysis
Center-leaning sources cover this story neutrally by presenting a comprehensive overview of the unfolding controversy surrounding the CDC. They detail the actions and statements of all key players—Sen. Cassidy, HHS Secretary Kennedy, congressional Democrats, and the White House—without adopting a particular stance. The reporting focuses on providing factual context and diverse perspectives on the leadership changes and vaccine advisory meeting.
"Cassidy's call to postpone the vaccine meeting is the second he's made under Kennedy's leadership — after he did the same in June — and represents a break with the HHS secretary."
CBS NewsArticles (3)
FAQ
Multiple CDC officials resigned due to disagreements with the Trump administration's and later Robert F. Kennedy Jr.'s vaccine policies, particularly regarding COVID-19 vaccine recommendations for children and vaccine advisory panel changes.
Robert F. Kennedy Jr. removed all 17 members of the CDC's Advisory Committee for Immunization Practices (ACIP) and appointed 17 new members, many of whom have vaccine-skeptic views, aiming to restore public trust and addressing alleged conflicts of interest.
The CDC, under Kennedy, stopped recommending COVID-19 vaccines for healthy children and pregnant women, shifting to a shared clinical decision-making model where vaccination decisions are made between individuals and doctors.
The 2025 vaccine schedule includes updated recommendations such as COVID-19 vaccine doses for adults aged 65 and older and immunocompromised individuals, with additional doses under shared clinical decision-making for some groups.
Due to the overhaul of the advisory panel and resulting internal turmoil, there have been calls to postpone upcoming vaccine advisory meetings to allow for adjustment to the new panel composition.
History
- This story does not have any previous versions.